119 related articles for article (PubMed ID: 8357165)
1. Differences in acetylcholine receptor-antibody interactions between extraocular and extremity muscle fibers.
Oda K
Ann N Y Acad Sci; 1993 Jun; 681():238-55. PubMed ID: 8357165
[TBL] [Abstract][Full Text] [Related]
2. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
Oda K; Shibasaki H
Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
[TBL] [Abstract][Full Text] [Related]
3. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
Wu X; Tüzün E
Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
5. Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?
Soltys J; Gong B; Kaminski HJ; Zhou Y; Kusner LL
Ann N Y Acad Sci; 2008; 1132():220-4. PubMed ID: 18567871
[TBL] [Abstract][Full Text] [Related]
6. Differences between ocular and generalized myasthenia gravis: binding characteristics of anti-acetylcholine receptor antibody against bovine muscles.
Hayashi M; Kida K; Yamada I; Matsuda H; Tsuneishi M; Tamura O
J Neuroimmunol; 1989 Feb; 21(2-3):227-33. PubMed ID: 2913046
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
MacLennan C; Beeson D; Buijs AM; Vincent A; Newsom-Davis J
Ann Neurol; 1997 Apr; 41(4):423-31. PubMed ID: 9124798
[TBL] [Abstract][Full Text] [Related]
8. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
[TBL] [Abstract][Full Text] [Related]
9. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
[No Abstract] [Full Text] [Related]
10. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
11. Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis.
Kaminski HJ; Li Z; Richmonds C; Lin F; Medof ME
Exp Neurol; 2004 Oct; 189(2):333-42. PubMed ID: 15380483
[TBL] [Abstract][Full Text] [Related]
12. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis.
Motomura M; Niwa M; Kataoka Y; Ootsuru I; Yoshimura T; Tsujihata M; Nagataki S
Neurosci Lett; 1992 Aug; 143(1-2):139-42. PubMed ID: 1436658
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in Myasthenia Gravis].
Higuchi O
Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
[TBL] [Abstract][Full Text] [Related]
14. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
[No Abstract] [Full Text] [Related]
15. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
16. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis.
Wang ZY; Okita DK; Howard J; Conti-Fine BM
Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393
[TBL] [Abstract][Full Text] [Related]
17. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody.
Pande R; Leis AA
Muscle Nerve; 1999 Nov; 22(11):1600-2. PubMed ID: 10514242
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of myasthenia gravis thymus to SCID mice.
Schönbeck S; Padberg F; Marx A; Hohlfeld R; Wekerle H
Ann N Y Acad Sci; 1993 Jun; 681():66-73. PubMed ID: 8357210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
